Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03686917 · ClinicalTrials.gov registry record
Validation of a CREATION Health Assessment Tool for Patients in a Diabetic Outpatient Population
A clinical trial, sponsored by AdventHealth.
- Completed
- Registry status
- 260
- Enrollment target
NCT03686917: Completed study, sponsored by AdventHealth.
NCT03686917 is a clinical trial that has completed, run by AdventHealth. The registered enrollment target is 260 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03686917 has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
Participants will complete a survey before an educational session, during the "break" of an educational session, or after the session.
Primary Outcome
Total score of 28 item survey. Survey scored using a 5-point scale: Strongly disagree, Disagree, Neutral, Agree, Strongly Agree
Interventions
- OTHER CHAT-P
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2019-10-31 |
What the finished NCT03686917 record still lists
NCT03686917 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CHAT-P is the first listed.
NCT03686917 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03686917 about?
NCT03686917 is a clinical study titled "Validation of a CREATION Health Assessment Tool for Patients in a Diabetic Outpatient Population". Participants will complete a survey before an educational session, during the "break" of an educational session, or after the session.
What is the current status of trial NCT03686917?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2018-10-01. Estimated completion is 2019-10-31.
What interventions are being tested in trial NCT03686917?
The interventions under investigation include: CHAT-P (OTHER).
Who is sponsoring clinical trial NCT03686917?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI